Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Drugs - Real World Outcomes
|
February 25, 2021
Identifying the Causes Increasing the Risk of Non-Adherence in Adult Patients with Asthma: An Analysis Combining Patient Survey Data with German Claims Data
Sabrina Müller, Ulf Maywald, Hartmut Timmermann, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
January 6, 2021
Extent of non-adherence and non-persistence in asthma patients: analysis of a large claims data set
Fränce Hardtstock, Ulf Maywald, Hartmut Timmermann, et al.
Journal of Cancer Research and Clinical Oncology
|
July 15, 2022
Real-world treatment of German patients with recurrent and advanced endometrial cancer with a post-platinum treatment: a retrospective claims data analysis
Antje Mevius, Florian Karl, Margarethe Wacker, et al.
Pharmacoeconomics
|
February 8, 2006
Combination vaccine against invasive meningococcal B and pneumococcal infections: potential epidemiological and economic impact in the Netherlands
Jasper M Bos, Hans C Rümke, Robert Welte, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
November 14, 2022
Epidemiology, treatment and health care resource use of patients with severe asthma in Germany - a retrospective claims data analysis
Fraence Hardtstock, Julia Krieger, Thomas Wilke, et al.
Journal of Asthma and Allergy
|
April 12, 2022
Use of Biologic Therapies in the Treatment of Asthma - A Comparative Real World Data Analysis on Healthcare Resource Utilization and Costs Before and After Therapy Initiation
Fraence Hardtstock, Julia Krieger, Thomas Wilke, et al.
Pharmacoeconomics
|
September 21, 2016
Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model
Christiaan Dolk, Martin Eichner, Robert Welte, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 24, 2012
Direct cost analysis of intensive care unit stay in four European countries: applying a standardized costing methodology
Siok Swan Tan, Jan Bakker, Marga E Hoogendoorn, et al.
Sexually Transmitted Infections
|
March 12, 2015
Chlamydia screening is not cost-effective at low participation rates: evidence from a repeated register-based implementation study in The Netherlands
G Ardine de Wit, Eelco A B Over, Boris V Schmid, et al.
Health and Quality of Life Outcomes
|
May 24, 2019
A DELPHI study on aspects of study design to overcome knowledge gaps on the burden of disease caused by serogroup B invasive meningococcal disease
Ole Marten, Florian Koerber, David Bloom, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Drugs - Real World Outcomes
|
February 25, 2021
Identifying the Causes Increasing the Risk of Non-Adherence in Adult Patients with Asthma: An Analysis Combining Patient Survey Data with German Claims Data
Sabrina Müller, Ulf Maywald, Hartmut Timmermann, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
January 6, 2021
Extent of non-adherence and non-persistence in asthma patients: analysis of a large claims data set
Fränce Hardtstock, Ulf Maywald, Hartmut Timmermann, et al.
Journal of Cancer Research and Clinical Oncology
|
July 15, 2022
Real-world treatment of German patients with recurrent and advanced endometrial cancer with a post-platinum treatment: a retrospective claims data analysis
Antje Mevius, Florian Karl, Margarethe Wacker, et al.
Pharmacoeconomics
|
February 8, 2006
Combination vaccine against invasive meningococcal B and pneumococcal infections: potential epidemiological and economic impact in the Netherlands
Jasper M Bos, Hans C Rümke, Robert Welte, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
November 14, 2022
Epidemiology, treatment and health care resource use of patients with severe asthma in Germany - a retrospective claims data analysis
Fraence Hardtstock, Julia Krieger, Thomas Wilke, et al.
Journal of Asthma and Allergy
|
April 12, 2022
Use of Biologic Therapies in the Treatment of Asthma - A Comparative Real World Data Analysis on Healthcare Resource Utilization and Costs Before and After Therapy Initiation
Fraence Hardtstock, Julia Krieger, Thomas Wilke, et al.
Pharmacoeconomics
|
September 21, 2016
Cost-Utility of Quadrivalent Versus Trivalent Influenza Vaccine in Germany, Using an Individual-Based Dynamic Transmission Model
Christiaan Dolk, Martin Eichner, Robert Welte, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 24, 2012
Direct cost analysis of intensive care unit stay in four European countries: applying a standardized costing methodology
Siok Swan Tan, Jan Bakker, Marga E Hoogendoorn, et al.
Sexually Transmitted Infections
|
March 12, 2015
Chlamydia screening is not cost-effective at low participation rates: evidence from a repeated register-based implementation study in The Netherlands
G Ardine de Wit, Eelco A B Over, Boris V Schmid, et al.
Health and Quality of Life Outcomes
|
May 24, 2019
A DELPHI study on aspects of study design to overcome knowledge gaps on the burden of disease caused by serogroup B invasive meningococcal disease
Ole Marten, Florian Koerber, David Bloom, et al.
Page
of 2